Devopharma ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Devopharma ApS
Devopharma ApS (CVR number: 38968254) is a company from GENTOFTE. The company recorded a gross profit of -3.1 kDKK in 2023. The operating profit was -3.1 kDKK, while net earnings were -3.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -3.1 %, which can be considered poor and Return on Equity (ROE) was -9.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 31.2 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Devopharma ApS's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -3.13 | -3.13 | -3.13 | -3.13 | -3.13 |
EBIT | -3.13 | -3.13 | -3.13 | -3.13 | -3.13 |
Net earnings | -3.13 | -3.13 | -3.13 | -3.13 | -3.13 |
Shareholders equity total | 43.75 | 40.63 | 37.50 | 34.38 | 31.25 |
Balance sheet total (assets) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Net debt | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Profitability | |||||
EBIT-% | |||||
ROA | -4.2 % | -3.1 % | -3.1 % | -3.1 % | -3.1 % |
ROE | -6.9 % | -7.4 % | -8.0 % | -8.7 % | -9.5 % |
ROI | -4.4 % | -3.4 % | -3.5 % | -3.6 % | -3.8 % |
Economic value added (EVA) | -2.97 | -2.81 | -2.65 | -2.50 | -2.34 |
Solvency | |||||
Equity ratio | 43.8 % | 40.6 % | 37.5 % | 34.4 % | 31.3 % |
Gearing | 114.3 % | 123.1 % | 133.3 % | 145.5 % | 160.0 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.9 | 0.8 | 0.8 | 0.8 | 0.7 |
Current ratio | 0.9 | 0.8 | 0.8 | 0.8 | 0.7 |
Cash and cash equivalents | |||||
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.